Covid-19 Tumult Prompts Rethink of Buy-Side Risk Management

Investment firms are making changes to their risk reports, stress tests and concentration limits.

Evolution rather than revolution. Now that markets have, at least for now, bounced back from March’s lows, this is how buy-side firms describe the impact of the Covid-19 crisis on risk management. But whether profound or otherwise, changes in approaches will be multiple and wide-spread.

For Sudi Mariappa, global head of portfolio risk management at Pimco, the metaphorical lesson from the experience is “[do] more exercise and eat healthy”.

“The evolution will be: continue to define what your

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here